Table 2. Surgical and Anesthetic Characteristics of 6 Patients with Angelman Syndrome Undergoing Anesthetic Care.
Patient (No), Age, Weight (kg) | Procedure Duration (min) | Anesthetic Typea | Analgesiab | PACU Duration (min) Disposition |
---|---|---|---|---|
1 | ||||
7 mo, 7 | MLB, EGD, 78 | Sevo/Prop | - | 68, outpatient |
8 mo, 7 | MRI, 117 | Sevo/Prop | - | 47, outpatient |
2 | ||||
2 y, 10 | MRI, 111 | Sevo/Prop | - | 101, outpatient |
2 y, 11 | Strabismus, 141 | Sevo | Fent/APAP | 95, outpatient |
3 y, 12 | T/A, MLB, 93 | Sevo | NSAID | 44, outpatient |
3 | ||||
7 y, 33 | T/A, 58 | Sevo | Morphine, LA | 32, outpatient |
4 | ||||
16 y, 47 | Dental, 90 | Mid/Prop/Des | Fent/NSAID, LA | 234, outpatient |
5 | ||||
8 y, 33 | EGD, 51 | Mid/ Sevo/Prop** | - | 36, outpatient |
8 y, 33 | EGD, 35 | Mid/ Sevo/Prop** | - | 45, outpatient |
8 y, 33 | EGD, 34 | Mid/ Sevo/Prop** | - | 22, outpatient |
8 y, 31 | T/A, EGD, 111 | Sevo, Atracuriumc | Fent, LA | 36, ICUd |
9 y, 31 | EGD, 24 | Sevo** | - | 39, outpatient |
20 y, 106 | EGD, 34 | Sevo/Prop** | - | 14, outpatient |
6 | ||||
28 y, 78 | LP, 44 | Mid/Prop/Iso Succinylcholine | LA | 53, ward |
28 y, 78 | PICC, 65 | Mid/Prop†† | Fent, LA | 43, ward |
28 y, 78 | CT, 22 | Mid/Prop†† | - | 57, ward |
34 y, 89 | LP, 77 | Mid/Prop/Ket†† | Fent, LA | 12, ICUe |
34 y, 89 | CT, 39 | Mid/Prop†† | - | 116, ward |
Abbreviations: APAP, acetaminophen; CT, computerized tomography scan; Des, desflurane; EGD, esophagogastroduodenoscopy; Fent, fentanyl; ICU, intensive care unit; Iso, isoflurane; Ket, ketamine; LA, infiltration of procedure site with local anesthetic; LP, lumbar puncture; min , minute; mo, months; MLB, microlaryngoscopy and bronchoscopy; MRI, magnetic resonance imaging scan; Mid, midazolam; NSAID, nonsteroidal antiinflammatory drug; PICC, peripherally inserted central catheter; Prop, propofol; Sevo, sevoflurane; T/A, adenotonsillectomy; y, years.
aCases were performed under general endotracheal anesthesia unless noted with ** to indicate general mask anesthesia or †† to indicate monitored anesthesia care.
bNo patient was administered opioid or nonopioid analgesic during Phase I postanesthesia recovery.
cAtracurium 10 mg was administered with induction, but was not reversed.
dPlanned ICU admission for postoperative monitoring of airway effort.
eAdmitted to ICU for treatment of on-going sepsis that was unrelated to procedure.